Physician profile
John I Cassis
NPI 1013137108
$204.54
in general payments reported to CMS, 2019-2025
7 companies · $23.23 in 2025
The $23.23 reported for 2025 was less than what a typical Prosthodontics provider received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $25.00 · 2023: $74.32 · 2024: $81.99 · 2025: $23.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $179.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nobel Biocare USA | $49.76 | 2023 | Nobelactive |
| Solventum Corporation | $38.01 | 2024 | 3m Scotchbond, Filtek, 3m Filtek |
| Colgate Oral Pharmaceuticals, INC. | $37.90 | 2024-2025 | |
| Straumann USA LLC | $25.00 | 2021 | |
| 3m Company | $24.56 | 2023 | Scotchbond Universal Plus, 3m Filtek, 3m Relyx |
| Voco America INC. | $15.63 | 2024 | Admira Fusion X-Tra, Ionostar Plus, Grandio So |
| Philips North America LLC | $13.68 | 2024 | (8614) Protectiveclean 4100-4300 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Cassis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.